Text Registration
Copyright Title
Translational Medicine in CNS Drug Development
Status
Published
on 14 Nov 2019
Year of Creation
2019
Copyright Claimant
Elsevier Inc
Registration Number
TX0008891775
on 14 Nov 2019Copyright Summary
The U.S. Copyright record (Registration Number: TX0008891775) dated 14 Nov 2019, pertains to an electronic file (eService) titled "Translational Medicine in CNS Drug Development" created in 2019. The copyright holder is Elsevier Inc, known for their creative contributions in text registration. For any inquiries concerning this copyrighted material, kindly reach out to Elsevier Inc.
Application Details
Registration Number
TX0008891775
Registration Date
11/14/2019
Year of Creation
2019
Agency Marc Code
DLC-CO
Record Status
New
Physical Description
Book, 442 p
First Publication Nation
United States
ISBN
9780128031612
Preexisting Material
permissioned materials
Notes
Rights Note: permissions@elsevier.com
Local Copyright Note: C.O. correspondence
Material Matter Claimed Note: text
Statements
Application Title Statement: Translational Medicine in CNS Drug Development
Author Statement: George Nomikos Domicile: United States Citizenship: United States Authorship: text
© 2024 reserved by Trademarkia
Show terms & conditions
Disclaimer: The information contained in this website is provided for informational purposes only, and should not be construed as legal advice. Although LegalForce RAPC Worldwide P.C., dba Trademarkia P.C., is a law firm (the “Firm”), your use of this website does not establish an attorney-client relationship with the Firm. Such a relationship can only be established after the Firm decides that it is willing and able to accept the engagement after a conflict check and after a written retainer agreement is agreed upon between you and the Firm. Your use of this website is also subject to our Terms of Use and Privacy Policy. ** The entry level subscription is a bundled price which requires a minimum of two billing cycles, or 6 months.